BDBM72343 4-methyl-N-[2-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]-1,2-dihydroacenaphthylen-1-yl]benzenesulfonamide::4-methyl-N-[2-[(4-methyl-1,2,4-triazol-3-yl)thio]-1,2-dihydroacenaphthylen-1-yl]benzenesulfonamide::4-methyl-N-[2-[(4-methyl-1,2,4-triazol-3-yl)thio]acenaphthen-1-yl]benzenesulfonamide::MLS000417465::SMR000242674::cid_4129801

SMILES Cc1c(F)ccc2c1CNCCc1[nH]c(=O)ccc1N1CN2c2cc(C(F)(F)F)c(Cl)cc2C1=O

InChI Key InChIKey=MBZWEGWHXAJYAS-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 72343   

TargetSodium channel protein type 10 subunit alpha(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandChemical structure of BindingDB Monomer ID 72343BDBM72343(2,8-Difluoro-9-methyl-3-(trifluoromethyl)-10,11,12...)
Affinity DataIC50: 3.98nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2026
Entry Details
US Patent